(Nasdaq: CTKB) today announced its inclusion on TIME’s 2026 list of America’s Growth Leaders. Presented in partnership with global data firm Statista, the inaugural ranking recognizes the ...

Amid the reduction of various government grant programs and global economic challenges that have tightened research funding, Cytek Biosciences, Inc.

FREMONT, Calif., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Amid the reduction of various government grant programs and global economic challenges that have tightened research funding, Cytek Biosciences, Inc. ...

A Czech scientist has contributed to understanding the function of the thymus—the training center of the immune system. T lymphocytes, key defensive cells, learn in the thymus not to mistake the ...

Antibodies serve as foundational tools across a broad range of research fields from immunology to oncology and infectious ...

Early CAR T cell expansion is associated with both therapeutic activity and inflammatory toxicity, such as cytokine release syndrome and neurotoxicity. Routine flow cytometry can reliably track ...

The assay is fast and simple and has already shown clinical utility, although its interpretation may be limited by reference ...

The company raised guidance by $25 million each for total revenue, adjusted EBITDA, and free cash flow to approximately $8.525 billion in revenue, $2.625 billion in adjusted EBITDA, and $1.225 billion ...

Glioblastoma—the most aggressive form of brain cancer—remains one of medicine's biggest challenges. Despite surgery, ...

Affinity Technologies, Inc. , a biotechnology company advancing early-stage diagnostics including CyPath® Lung, the Company's noninvasive test for lung cancer, today announced that the Australian ...

Background Globally, an estimated 296 million individuals live with chronic hepatitis B virus (HBV) infection, carrying ...